Inovio Pharmaceuticals Inc vs Trade Desk Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Trade Desk Inc trades at $13.53 (market cap $6.37B). The key difference: Trade Desk Inc is far larger — about 81.1× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | TTD | |
|---|---|---|
Market Cap | $78.55M | $6.37B |
Sector | Health | Technology |
52-Week High | $2.87 | $55.36 |
52-Week Low | $0.66 | $13.39 |
Enterprise Value | $49.56M | $5.32B |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →